Immutep
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.About IMMP
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731).
CEOMarc Voigt
CEOMarc Voigt
Employees—
Employees—
HeadquartersSydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded1987
Founded1987
Employees—
Employees—
IMMP Key Statistics
Market cap64.92M
Market cap64.92M
Price-Earnings ratio-1.25
Price-Earnings ratio-1.25
Dividend yield—
Dividend yield—
Average volume4.36M
Average volume4.36M
High today$0.4554
High today$0.4554
Low today$0.427
Low today$0.427
Open price$0.4554
Open price$0.4554
Volume721.87K
Volume721.87K
52 Week high$3.53
52 Week high$3.53
52 Week low$0.2928
52 Week low$0.2928
IMMP News
TipRanks 1d
Immutep receives noncompliance notification from NasdaqImmutep (IMMP) advises that it has received a written notification from Nasdaq regarding non-compliance with the Nasdaq minimum bid price requirement. Nasdaq Li...
Analyst ratings
67%
of 6 ratingsBuy
33.3%
Hold
66.7%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.